The weekly litigation news digest is live. Subscribe now
Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression
Patent No. EP3031920 (titled "Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression") was filed by Ionis Pharmaceuticals on Jul 19, 2011. The application was issued on Aug 21, 2019.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3031920
- Application Number
- EP16153949A
- Filing Date
- Jul 19, 2011
- Status
- Revoked
- Feb 19, 2021
- Publication Date
- Aug 21, 2019
- External Links
- Slate, EP3031920B1, Google Patents